Skip to main content

Table 1 Demographics, hemodynamic and CTPA data

From: Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension

  IPAH Sch-PAH p
Gender    
 Male 4 (16 %) 4 (18 %) ns
 Female 21 (84 %) 18 (81 %)  
Age 40 ± 13 48 ± 13 0.019
Functional class    
 I/II 7 (28 %) 7 (32 %) ns
 III/IV 18 (72 %) 15 (68 %)  
Hemodynamics    
 mPAP (mmHg) 63 ± 23 56 ± 23 ns
 RAP (mmHg) 15 ± 11 9 ± 4 0.018
 PAOP (mmHg) 12 ± 6 15 ± 7 ns
 PVR (IU) 15.4 ± 5.1 10.2 ± 6.1 0.009
 CO (mL/min) 4.9 ± 1.8 3.8 ± 1.2 0.03
CTPA measurements    
MPAD, cm 3.7 ± 1.1 4.5 ± 1.8 0.018
 RPAD, cm 2.58 ± 0.47 3.16 ± 0.91 0.009
 LPAD, cm 2.5 ± 0.4 2.7 ± 0.6 ns
  1. IPAH idiopathic pulmonary arterial hypertension, Sch-PAH schistosomiasis associated pulmonary hypertension, NYHA FC New York Heart Association functional class, mPAP mean pulmonary arterial pressure, RAP right atrial pressure, PAOP pulmonary artery occlusion pressure, PVR pulmonary vascular resistance, CO cardiac output, MPAD main pulmonary artery diameter, RPAD right pulmonary artery diameter, LPAD left pulmonary artery diameter, ns non significant